Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Relay Therapeutics (RLAY) Interest Coverage Ratio (2020 - 2023)

Relay Therapeutics (RLAY) has disclosed Interest Coverage Ratio for 4 consecutive years, with 33725.67 as the latest value for Q1 2023.

  • On a quarterly basis, Interest Coverage Ratio fell 1029.19% to 33725.67 in Q1 2023 year-over-year; TTM through Dec 2023 was 124333.33, a 772.44% decrease, with the full-year FY2020 number at 3487.25, down 140.65% from a year prior.
  • Interest Coverage Ratio was 33725.67 for Q1 2023 at Relay Therapeutics, down from 2986.71 in the prior quarter.
  • In the past five years, Interest Coverage Ratio ranged from a high of 4373.5 in Q4 2020 to a low of 33725.67 in Q1 2023.
  • A 4-year average of 9628.26 and a median of 7321.4 in 2020 define the central range for Interest Coverage Ratio.
  • Peak YoY movement for Interest Coverage Ratio: soared 64.78% in 2022, then crashed 1029.19% in 2023.
  • Relay Therapeutics' Interest Coverage Ratio stood at 4373.5 in 2020, then crashed by 293.92% to 8481.0 in 2021, then skyrocketed by 64.78% to 2986.71 in 2022, then plummeted by 1029.19% to 33725.67 in 2023.
  • Per Business Quant, the three most recent readings for RLAY's Interest Coverage Ratio are 33725.67 (Q1 2023), 2986.71 (Q1 2022), and 8481.0 (Q1 2021).